Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled, randomised study about the efficacy and tolerance of Cefixime compared to Nitrofurantoin;Reinfektionsprophylaxe rezidivierender harnwegsinfektionen im kindesalter. Ergebnisse einer offenen, kontrollierten und randomisierten studie zur wirksamkeit und verträglichkeit von Cefixim im vergleich zu Nitrofurantoin

Klinische Padiatrie

Volumn 214, Issue 6, 2002, Pages 353-358

  Lettgen, B ^a,c   Troster K ^b  

^a Darmstaedte Kinderkliniken   (Germany)

^b MERCK KGAA   (Germany)

^c Darmstadter Kinderkl Prin Margaret   (Germany)

Author keywords

Cefixime; Children; Recurrent urinary tract infections

Indexed keywords

CEFIXIME; NITROFURANTOIN; ANTIINFECTIVE AGENT; URINARY TRACT ANTIINFECTIVE AGENT;

ARTICLE; BODY WEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PILOT STUDY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; URINARY TRACT INFECTION; AGE; COMPARATIVE STUDY; FOLLOW UP; INFANT; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TIME;

AGE FACTORS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; CEFIXIME; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; NITROFURANTOIN; PILOT PROJECTS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 0036827106     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35368     Document Type: Article

References (32)

1. Ahmed SM, Swedlund SK. Evaluation and treatment of urinary tract infections in children. Am Fam Physician 1998; 57 (7): 1573-1580
2. Barry AL, Jones RN. Cefixime spectrum of antibacterial activity against 16016 clinical isolates. Pediatr Infect Dis J 1987; 6: 954-957 EMD 49653-288
3. Bollgren I. Antibacterial prophylaxis in children with urinary tract infection. Acta Paediatr Suppl 1999; 431: 48-52
4. Breithaupt H. Grundlagen der chemoprophylaxe unter besonderer berücksichtigung von trimethoprim und nitrofurantoin aus klinischpharmakologischer sicht. Akt Urol 1987; 18 (Suppl): 2-5
5. Brendstrup L, Hjelt K, Petersen KE, Petersen S, Andersen EA, Daugbjerg PS, et al. Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. Acta Paediatr Scand 1990; 79: 1225-1234
6. Brittain DC, Scully BE, Hirose T, Neu HC. Pharmacokinetic and bacterial characteristics of oral cefixime. Clin Pharmacol Ther 1985; 38: 590-594
7. Brumfitt W, Hamilton-Miller JMT, Walker S, Roberts D. Cefaclor as a prophylactic agent for recurrent urinary tract infections. A comparative trial with macrocrystalline nitrofuration. Drugs Exp Clin Res 1992; 18 (6): 239-244
8. Brumfitt W, Hamilton-Miller JMT. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection 1995; 23: 98-102
9. Cox CE. Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections. Urology 1989; 34: 322-326
10. Finegold SM, Ingram-Drake L, Gee R, Reinhardt J, Edelstein MAC, MacDonald K, et al. Bowel flora changes in humans receiving cefixime (CL 284;635) or cefaclor. Antimicrob Agents Chemother 7987; 31: 443-446
11. Guay D. An update on the role of nitrofurans in the management of urinary tract infections. Drugs 2001; 61 (3): 353-364
12. Hori C, Hiraoka M, Tsukuhara H, Tsuchida S, Sudo M. Intermittent trimethoprim-sulfamethoxazole in children with vesicoureteral reflux. Pediatr Nephrol 1997; 11: 328-330
13. Hubmann R. Unspezifische entzündungen der nieren und ableitenden harnwege. Hohenfellner R, Zingg EJ (Hrsg). Diagnostik, Entzündungen Tumoren. Urologie in Klinik und Praxis: Thieme, Stuttgart, 1983; 1: 346-363
14. Jodal U, Koskimíes O, Hanson E, Löhr G, Olbing H, Smellie J, et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long-term antibacterial prophylaxis. J Urol 1992; 148: 1650-1652
15. Le-Saux N, Pham B, Moher D. Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: A systematic review. CMAJ 2000; 163 (5): 523-529
16. Lettgen B. Harnwegsinfektionen im Kindesalter. Altes und Neues. Klin Pädiatr 1993; 205: 325-331 EMD 49653-656
17. Lettgen B. Prevention of recurrent urinary tract infections in female children. Curr Ther Res 1996; 57: 464-475
18. Linshaw MA. Controversies in childhood urinary tract infections. World J Urol 1999; 17: 383-395
19. Mangiarotti P, Pizzini C, Fanos V. Antibiotic prophylaxis in children with relapsing urinary tract infections: Review. J Chemother 2000; 12 (2): 115-123
20. Naber KG, Vogel F, Scholz H, die Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. Rationaler einsatz oraler antibiotika in der Praxis. PEG-Empfehlungen. Chemother J 1998; 1: 6-26
21. Nahata MC. Guidelines for antimicrobial prophylaxis. J Clin Pharm Ther 1996; 21: 255-260
22. Olbing H. Chemoprophylaxe der harnwegsinfektionen beim kind. Akt Urol 1987; 18 (Suppl): 16-18
23. Osmon DR. Antimicrobial prophylaxis in adults. Mayo Clin Proc 2000; 75: 98-109
24. Sammann A, Schäfer V, Shah PM, Knothe H. Einfluss von cefixim auf die darm- und rachenflora. Fortschr Antimikr Antineoplast Chemother 1987; 6-8: 1241-1247
25. Sanders CC. β-lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance. Antimicrob Agents Chemother 1989; 33: 1313-1317
26. Scholz H, Naber KG. die Expertenkommission der Paul-Ehrich-Gesellschaft für Chemotherapie e.V. Einteilung der oralcephalosporine. Chemother J 1999; 8: 227-231
27. Shapiro E, Elder JS. The office management of recurrent urinary tract infection and vesicoureteral reflux in children. Urol Clin North Am 1998; (4): 725-734
28. Steffens J, Fisch M. Der vesikorenale reflux. Urologe A 1997; 36: 187-192
29. Titz B, Guggenbichler JP. Einfluss verschiedener neuer oraler cephalosporine auf die zusammensetzung und das resistenzverhalten der stuhlflora. Fortschr Antimikr Antineoplast Chemother 1993; 12-2: 349-353
30. Valensiek W, Westenfelder M. Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomised study. Int Urol Nephrol 1992; 24: 3-10
31. Weißbach L, Segal A, Tröster K. Wirksamkeit und verträglichkeit von cefixim bei der behandlung von akuten pyelonephritiden. Infection 1990; 18 Suppl 3: 140-144
32. Welling U, Olbing H. Antibiotikaresistenz der Erreger von Harnwegsinfektionen bei Kindern. Pädiat Prax 1989/1990; 39: 39-48